<DOC>
	<DOCNO>NCT00000530</DOCNO>
	<brief_summary>To determine relative efficacy usual medical care course treatment thermal biofeedback reduce vasospastic attack characteristic Raynaud 's syndrome . Also , confirm frequency severity attack , examine role psychophysiological factor precipitate attack , assess influence treatment health quality life .</brief_summary>
	<brief_title>Raynaud 's Treatment Study ( RTS )</brief_title>
	<detailed_description>BACKGROUND : Primary Raynaud 's phenomenon peripheral vascular disorder result vasospastic attack provoke cold and/or emotional stress . Attacks often occur finger , may occur extremity well . DESIGN NARRATIVE : Randomized . Patients assign one four treatment group : slow release Nifedipine , calcium channel blocker ; pill placebo ; temperature biofeedback ; electromyograph biofeedback frontalis muscle . The primary endpoint reduction number vasospastic attack . Other endpoint include : measure Raynaud 's attack include frequency , severity , duration , response laboratory-based cold challenge , quality life .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>Men woman document primary secondary Raynaud 's syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2004</verification_date>
</DOC>